Trials / Completed
CompletedNCT04248972
Effects of Photobiomodulation in a Population Suffering From Fibromyalgia
Short- and Long-term Effects of Photobiomodulation on Pain, Functionality, Tissue Quality, Central Sensitisation and Psychological Factors in a Population Suffering From Fibromyalgia: Protocol for a Triple-blinded Randomized Clinical Trial.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- University of Malaga · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The development of an integral and global treatment to improve the quality of life in those with fibromyalgia syndrome (FMS) is challenging, thus a whole body Photobiomodulation (PBM) therapy program is proposed as an effective option.
Detailed description
This study is a randomized, placebo-controlled clinical trial. Participants will be recruited in a private care practice and randomized to receive either a whole body Photobiomodulation (PBM) therapy program or placebo. Primary outcomes will be pain (Numeric Pain Rating Scale; Widespread Pain Index; Symptom Severity Score), functionality (Fibromyalgia Impact Questionnaire; The Leisure Time Physical Activity Instrument), quality of soft tissue (elastography) and central sensitisation (pain pressure threshold and the Autonomic Symptom Profile). Secondary outcomes will be psychological factors (Pain Catastrophising scale, Tampa Scale, Self-Efficacy questionnaire). Assessments will be at baseline, after treatment 6, immediately following the last treatment (4 weeks), and then 2 weeks and at 3 monthly follow up intervals to 6 months after completion of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PBM | A whole body red light therapy (NovoTHOR®) will be carried out during 20 minutes |
| OTHER | PLACEBO PBM | A placebo whole body red light will be carried out during 20 minutes |
Timeline
- Start date
- 2021-01-30
- Primary completion
- 2021-07-30
- Completion
- 2022-01-30
- First posted
- 2020-01-30
- Last updated
- 2022-02-28
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04248972. Inclusion in this directory is not an endorsement.